Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Targeting heparanase for cancer therapy at the tumor-matrix interface.

Literature DB >> 22655968

Targeting heparanase for cancer therapy at the tumor-matrix interface.

Ralph D Sanderson, Renato V Iozzo.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2012 PMID： 22655968 DOI： 10.1016/j.matbio.2012.05.001

Source DB: PubMed Journal: Matrix Biol ISSN： 0945-053X Impact factor: 11.583

Keyword Cloud
Cited

× No keyword cloud information.

16 in total

1. Functional and structural characterization of a heparanase.

Authors: Lisa Bohlmann; Gregory D Tredwell; Xing Yu; Chih-Wei Chang; Thomas Haselhorst; Moritz Winger; Jeffrey C Dyason; Robin J Thomson; Joe Tiralongo; Ifor R Beacham; Helen Blanchard; Mark von Itzstein
Journal: Nat Chem Biol Date: 2015-11-02 Impact factor: 15.040

Review 2. An introduction to proteoglycans and their localization.

Authors: John R Couchman; Csilla A Pataki
Journal: J Histochem Cytochem Date: 2012-09-26 Impact factor: 2.479

3. Heparanase and cancer progression: New directions, new promises.

Authors: Gil Arvatz; Marina Weissmann; Neta Ilan; Israel Vlodavsky
Journal: Hum Vaccin Immunother Date: 2016-04-07 Impact factor: 3.452

Review 4. The role of perlecan and endorepellin in the control of tumor angiogenesis and endothelial cell autophagy.

Authors: Stephen Douglass; Atul Goyal; Renato V Iozzo
Journal: Connect Tissue Res Date: 2015-07-16 Impact factor: 3.417

5. Chemotherapy induces expression and release of heparanase leading to changes associated with an aggressive tumor phenotype.

Authors: Vishnu C Ramani; Israel Vlodavsky; Mary Ng; Yi Zhang; Paola Barbieri; Alessandro Noseda; Ralph D Sanderson
Journal: Matrix Biol Date: 2016-03-22 Impact factor: 11.583

Targeting heparanase for cancer therapy at the tumor-matrix interface.

1. Functional and structural characterization of a heparanase.

Review 2. An introduction to proteoglycans and their localization.

3. Heparanase and cancer progression: New directions, new promises.

Review 4. The role of perlecan and endorepellin in the control of tumor angiogenesis and endothelial cell autophagy.

5. Chemotherapy induces expression and release of heparanase leading to changes associated with an aggressive tumor phenotype.

Review 6. Involvement of heparanase in atherosclerosis and other vessel wall pathologies.

Review 7. Dichotomy of decorin activity on the insulin-like growth factor-I system.

Review 8. Opposing Functions of Heparanase-1 and Heparanase-2 in Cancer Progression.

9. Endorepellin evokes autophagy in endothelial cells.

10. Heparanase cooperates with Ras to drive breast and skin tumorigenesis.